KKR & Co. reported a 9.7% stake in Henry Schein, Inc. as of March 10, according to an SEC filing. This disclosure provides an update on the private-equity firm's significant investment in the healthcare products distributor.
The reported stake follows Henry Schein's announcement on January 29, 2025, of a strategic investment by KKR, which included KKR becoming the largest non-index fund shareholder. The initial agreement involved a $250 million investment.
This confirmed ownership percentage by KKR reinforces the strategic partnership aimed at enhancing Henry Schein's operations and driving shareholder value. KKR representatives have also joined Henry Schein's Board of Directors as part of the agreement.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.